What Has Been the Progress and Growth of the Pharmaceutical Drug Delivery Market in Recent Years?
The pharmaceutical drug delivery market has seen considerable growth due to a variety of factors.
• In the past few years, the market size for pharmaceutical drug delivery has significantly expanded. This growth is expected to continue, rising from $1794.75 billion in 2024 to $1901.48 billion in 2025. This increase represents a compound annual growth rate (CAGR) of 5.9%.
This progress throughout the historic period can be linked to factors such as the higher occurrence of chronic diseases, burgeoning demand for biologics, an upsurge in research and development investments by pharmaceutical corporations, the growing need for individualized medicine, and an increased emphasis on patient compliance.
What Can Be Expected from the Pharmaceutical Drug Delivery Market in the Coming Years?
The pharmaceutical drug delivery market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of pharmaceutical drug delivery is projected to significantly expand in the upcoming years, reaching $2497.33 billion in 2029 with a compound annual growth rate (CAGR) of 7.1%.
The augmented growth in this forecast period can be ascribed to the increasing need for self-administration of medications, a rise in home healthcare adoption, a surge in demand for targeted drug delivery, a growing elderly population, and regulatory backing for drug delivery technologies. Key trends for this period include the development of drug delivery technologies, integration of telemedicine, utilization of 3D printing in drug delivery, targeted drug delivery systems, and ongoing manufacturing processes.
What Are the Critical Driver Fuelling the Pharmaceutical Drug Delivery Market's Growth?
The escalating occurrence of chronic illnesses is anticipated to drive the expansion of the pharmaceutical drug delivery market in the future. The term 'prevalence of chronic diseases' denotes the total count of ongoing cases of chronic ailments in a specific population at any given time. Pharmaceutical drug delivery aids patients afflicted with chronic diseases by transporting a pharmaceutical drug to a certain part of the body for treating various ailments. For example, the World Health Organization, a specialized agency in Switzerland of the United Nations, states that noncommunicable diseases lead to the death of 41 million individuals annually, which makes up 71% of all deaths globally, with most of these deaths arising from cardiovascular diseases. Consequently, the escalating occurrence of chronic diseases is boosting the growth of the pharmaceutical drug delivery market.
How Is the Pharmaceutical Drug Delivery Market segmented?
The pharmaceutical drug delivery market covered in this report is segmented –
1) By Route Of Administration: Oral, Ocular, Pulmonary, Nasal, Injectable, Topical, Other Routes
2) By Application: Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, Autoimmune Diseases, Other Applications
3) By End-User: Hospitals, Home Care Settings, ASC Or Clinics, Other End Users
Subsegments:
1) By Oral: Tablets, Capsules, Liquids, Powders
2) By Ocular: Eye Drops, Ocular Inserts, Ocular Implants
3) By Pulmonary: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers
4) By Nasal: Nasal Sprays, Nasal Gels, Nasal Powders
5) By Injectable: Intravenous (IV) Injections, Intramuscular (IM) Injections, Subcutaneous (SC) Injections, Biologics And Biosimilars
6) By Topical: Creams, Ointments, Gels, Transdermal Patches
7) By Other Routes: Sublingual, Buccal, Rectal, Intranasal
Pre-Book The Pharmaceutical Drug Delivery Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing the Pharmaceutical Drug Delivery Market?
The strategy of forming strategic partnerships is increasingly embraced by leading corporates in the pharmaceutical drug delivery market. The goal is to identify new transport objectives and shuttle molecules, thus improving the delivery of medication to the brain. Strategic partnerships involve companies drawing on each other's capabilities and assets for the mutual advantage and success. As an illustration, in September 2023, Cordance Medical, a medical equipment manufacturing company in the US, established a strategic alliance with EXACT Therapeutics to simplify the process of drug delivery to the brain. This partnership integrates Cordance Medical's NeuroAccess platform, which provides a non-surgical method to penetrate the blood-brain barrier, with EXACT Therapeutics' Acoustic Cluster Therapy (ACT) technology. An improved treatment approach for brain conditions such as tumors and neurodegenerative diseases is the desired outcome of this collaboration, by ensuring easier access for medications to the brain. EXACT Therapeutics is a British clinical-stage biopharmaceutical organization.
Who Are the Key Players in the Pharmaceutical Drug Delivery Market?
Major companies operating in the pharmaceutical drug delivery market include:
• 3M Company.
• AbbVie Inc.
• Amgen Inc.
• AstraZeneca plc
• Bayer AG
• Becton Dickinson And Company
• C. H. Boehringer Sohn AG & Co. KG
• Boston Scientific Corporation
• Bristol-Myers Squibb Company
• Consort Medical plc
• Eli Lilly and Company
• Emergent Biosolutions Inc.
• F. Hoffmann-La Roche AG
• GlaxoSmithKline plc
• Johnson & Johnson
• Kite Pharma Inc.
• Merck & Co Inc.
• Nemera France SAS
• Novartis AG
• Pfizer Inc
• Sanofi S. A.
• SHL Medical AG
• Teva Pharmaceuticals Industries Ltd.
• West Pharmaceutical Services Inc.
• Aerogen Pharma Limited
• AptarGroup Inc.
• Biocon Ltd.
• Catalent Inc.
• Evonik Industries AG
• Inovio Pharmaceuticals Inc.
• Mylan NV
• Sensile Medical Inc.
• Ypsomed Holding AG
What Is The Most Dominant Region In The Pharmaceutical Drug Delivery Market?
North America was the largest region in the pharmaceutical drug delivery market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
